By Colin Kellaher Shares of Taro Pharmaceutical Industries jumped more than 25% in premarket trading Tuesday after majority shareholder Sun Pharmaceutical Industries disclosed that it had made. | May 30, 2023
Taro Pharmaceutical Industries Ltd. today provided unaudited financial results for the quarter and year ended March 31, 2023.
Quarter ended March 31, 2023 Highlights ─ compared to March. | May 23, 2023
Taro Pharmaceutical Industries Ltd. announced today that it plans to release its financial results for the year ended March 31, 2023, after the close of market on Tuesday, May 23, 2023.
The. | May 18, 2023